Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event
    Summit & Event ：
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
    Learn More>
    Wealth & Capital Management
    Insurance & Finance
    Healthcare & Pharma
    Retail & FMCG
    Travel & Transportation
  • Shine Speaker Bureau
    Shine Speaker Bureau：
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
    Learn More>
    The Leader Networks
    Advisor
    Think-Tank
  • Shine Advisor
    Shine Advisor：
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
    Learn More>
    Briefing
    Consensus
    Customized Research
  • Shine Event Service
    Shine Event Service：
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
    Learn More>
Guest Information
Joan Shen
Joan Shen
发布时间: 2018 - 11 - 09
点击次数: 0
Positions：
Company： I-Mab Biopharma Co., Ltd
个人简介：
Joan Huaqiong Shen, M.D., Ph.D., is a US Board-certified physician and holds a PhD in life sciences from Indiana University School of Medicine where she had fellowship trainings in endocrinology, psychopharmacology and clinical pharmacology and where she and was appointed as an adjunctive professor in the department of psychiatry. Joan also had postdoctoral trainings in endocrinology, psychopharmacology and clinical pharmacology in the Unite States. Dr. Shen serves in many executive positions in Eli Lilly &Company, Wyeth, Pfizer, Hengrui and Johnson & Johnson, such as the China clinical head at Pfizer, Chief Medical Officer at Jiangsu Hengrui Medicine and China Development Head of Janssen Pharma J&J. In Hengrui, she built the largest clinical team among domestic pharma companies and led successful trials in China, US and Australia. At Janssen, She oversaw all clinical development programs in China. She gained rich experiences of working with FDA, EMEA, CNDA (previously CFDA), PMDA, KFDA and etc.  Joan joined I-Mab biopharma as the head of R&D in 2017.Dr. Shen was elected for the co-chair of RDPAC’s R&D core team and was granted the honor of “Talent of Innovation” by the “National Thousand Talent Program”. She also sits in the executive committee of China New Drug Research Evaluation Committee. She holds academic positions as the guest professor of Beijing University Clinical Research Institute.
查看详情>>
Yong-jiang Hei
Yong-jiang Hei
发布时间: 2018 - 11 - 09
点击次数: 0
Positions：
Company： Zai Lab
个人简介：
Dr. Hei is the CMO at Zai Lab where he oversees the clinical development and portfolio strategy for all the oncology projects.  Prior to Zai Lab, Dr. Hei was the Corporate VP and CMO at Qilu Pharmaceuticals where he led the overall clinical development functions and supported business development and strategic alliances.  Previously, Dr. Hei worked at the San Diego-based biotechnology company Ambrx Inc. for more than 2 years as the CMO responsible for the clinical strategy and operations, focusing on antibody-drug conjugates (ADCs) and CD3-based biospecifics.  Prior to Ambrx, Dr. Hei had worked at Amgen for more than 9 years before joining Ambrx, initially as the Head of Oncology Medical Affairs, and subsequently as an Executive Medical Director in Oncology Global Development in the capacity of a group or project leader for several oncology pipeline molecules and marketed products including the small molecules VEGF inhibitor motesanib and monoclonal antibodies targeting the death receptor DR4/5 (conatumumab) or the EGFR (panitumumab or Vectibix®).  Additionally, during his tenure at Amgen, Dr. Hei built the clinical medical teams for Amgen China in Shanghai and led the product development and clinical operations function for Amgen China.  Before Amgen, Dr. Hei worked for a few years at Novartis oncology as the Senior Global Brand Medical Director/Executive Director leading the clinical development and medical affairs teams for zoledronic acid (Zometa®), and for a few years at Roche Laboratories as the oncology Medical Director supporting capecitabine (Xeloda®) and other oncology projects.
查看详情>>
Mingde Xia
Mingde Xia
发布时间: 2018 - 11 - 09
点击次数: 0
Positions： Senior Director
Company： Johnson & Johnson Innovation Center AP
个人简介：
Dr. Mingde Xia is currently a Senior Director of Johnson & Johnson Innovation Center AP. He focuses on business partnership in mainland China, Hong Kong, and Taiwan, etc. with universities, institutes, investors and innovative companies for J & J worldwide pharmaceuticals, medical device / diagnostic products and OTC / consumer business, through investment, incubation, co-development, license and other collaboration vehicles. He has been working with Johnson & Johnson since 1999 after career track at China Pharmaceutical University and Yale University, and has successfully led / executed over 50 projects external collaboration for Johnson & Johnson three sectors. He is a guest / adjunct professor at the Chinese Academy of Sciences, a major inventor / author of over 60 patents / publications, a reviewer for a number of top quality international scientific journals, and an invited speaker for many international pharmaceutical conferences / forums. He received awards from American Chemical Society, Johnson & Johnson and different universities. He has actively involved in Sino-American Pharmaceutical Professionals Association (SAPA President 2009, Board of Directors 2008-present) and organized many international conferences in USA and Asia.
查看详情>>
Lynn Yang
Lynn Yang
发布时间: 2018 - 11 - 09
点击次数: 0
Positions：
Company：
个人简介：
Lynn Yang, focusing on healthcare investment. Prior to joining Sequoia Capital in May,2015, Lynn worked at Legend Capital healthcare team. Lynn accomplished investment deals in different area of healthcare industry. Before setting her foot in venture capital, Lynn worked as business development manager in Johnson & Johnson and product manager at GE Healthcare.   Mrs. Yang holds a MBA from Duke University and Master of Clinical Science from Huazhong Technology University.
查看详情>>